WILMINGTON, MA--(Marketwire - Mar 12, 2013) - Implant Sciences Corporation (OTCQB: [ IMSC ]), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has been featured as the cover story in the February 2013 issue of Government Security News (GSN). The article is entitled, "Implant Sciences Earns TSA's Seal of Approval for its Quantum Sniffer." With a circulation of over 45,000 subscribers comprised of leading government security officials, and a website with over 80,000 page views per month, GSN is considered the authoritative publication in the government security marketplace. The article can be viewed at [ http://bit.ly/Zq16BF ].

"TSA approval has opened the door for freight forwarders and carriers to begin serious evaluations of the QS-B220. The Government Security News article will help raise awareness of the product, leading to more evaluations," stated Dr. Darryl Jones, Vice President of Sales and Marketing at Implant Sciences. "Between the upcoming expiration dates for older screening systems, and the usage and performance advantages of Implant Sciences' technology, we expect that these evaluations will yield significant sales over the next several months."

"Achieving TSA approval has been one of the major goals the management team has had for Implant Sciences. The Company realized this goal through the dedication and hard work of all our employees, and we are pleased to see the team's efforts recognized publicly by an important publication like Government Security News," added Implant Sciences' President and CEO, Glenn D. Bolduc. "This is only the first of many approvals, qualifications, and certifications that we have set our sights on, and I can assure you that this team will not rest until it has achieved them all."

To view the complete February 2013 issue of Government Security News, visit [ http://www.gsnmagazine.com/ ].

About the Quantum Sniffer™ QS-B220 Desktop Explosives Trace Detector

The TSA-approved [ Quantum Sniffer QS-B220 ] uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, as well as drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and internal automatic self-calibration, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 desktop explosives and drugs trace detector has received TSA approval for air cargo screening and a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at [ www.implantsciences.com ].

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risk that we will be required to repay all of our indebtedness to our secured lender, DMRJ Group, by March 31, 2013; that if we are unable to satisfy our obligations to DMRJ and to raise additional capital to fund operations, DMRJ may seize our assets and our business may fail; the risk that we continue to incur substantial operating losses and may never be profitable; the risk that liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; the risk that we may not be able to retain our management and key employees or to identify, hire and retain additional personnel as needed; the risks that we may not be able to enforce our patent and other intellectual property rights or operate without infringing on the proprietary rights of others; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.